PROthrombin Time Electronic ASsistant

Patients Venous Thrombosis

Strokes

Pulmonary Embolism

Artificial Aortic Valve

Arterial Embolism

HISTORY

STOCK & DOSAGE

REMINDERS FIND A LAB

COMMUNITY

Collecting statistical data for better future

treatments

Creating a network-community between

patients

Niche business strategy: narrow-scope segment of the market with

customer-oriented service. Software-as-a-service approach.

Market Entry Point: Distribution to the end-user through the web

POS and mobile application markets.

Size of the Market: 100.000.000 globally

Target group: Patients who receive a blood-regulating,

anticoagulant medication.

PRO.T.E.AS

MARKETING PLAN

Competitive advantage : Introducing an innovative service to a very specific market segment. A unique service to facilitate and optimize the anticoagulant medication treatment and monitoring.

No sufficient bargaining power of suppliers

Not known substitute services

until now

Not known existing rivalry competitors

No sufficient bargaining power of

customers

• Low switching costs • Expected Retaliation

Business Model

NUMBERS…

SWOT Analysis

S No fixed costs Low operating costs High Added Value Database

W Easily initiated

business model Legal regulations

T No entry barriers Low switching costs Emerging Competition

O

Data harvesting for new medications New Market Business model adaptable to possible competition

A challenging future…

MAKE IT HAPPEN HELP LAUNCH

IGNITE FURTHER MED APPS

ELDERLY PATIENTS

THANK YOU MENTORS & ORGANIZERS

MARIOS BIKOS ~ THRASYVOULOS KARYDIS ~ FILIPPOS KALLIARAS NIKOS BARBAKOS ~ THANASIS PARASCHOS

TEAM

PROthrombin Time Electronic ASsistant